Search Reports
Categories
Categories

Global Companion Diagnostics (CDx) Development Services Market

Global Companion Diagnostics (CDx) Development Services Market Research Report 2025(Status and Outlook)

Report Code : MED2247
Published Date : 17 July, 1905 | No of Pages: 166

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports


Report Overview
Companion Diagnostics (CDx) Development Services refer to a specialized set of services provided by companies or institutions that focus on the development, validation, and commercialization of diagnostic tests. These tests are designed to identify specific biomarkers or genetic profiles in patients, which can predict their response to certain therapies. The primary goal of these services is to enable personalized medicine by matching the right treatment to the right patient, thereby improving treatment efficacy and reducing side effects. The process involves close collaboration between diagnostic developers, pharmaceutical companies, and regulatory bodies to ensure that the diagnostic tests meet the necessary scientific, regulatory, and quality standards. This includes the development of assays, clinical validation studies, and the integration of these tests into clinical practice, ultimately leading to better patient outcomes and more efficient healthcare resource utilization.

This report provides a deep insight into the global Companion Diagnostics (CDx) Development Services market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Companion Diagnostics (CDx) Development Services Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Companion Diagnostics (CDx) Development Services market in any manner.
Global Companion Diagnostics (CDx) Development Services Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Geneuity-Clinical Research Services
Interpace Biosciences
Labcorp
Quest Diagnostics
Q² Solutions
ResearchDx
Almac Diagnostic Services
Biocartis
Cerba Research
Eurofins Scientific
MLM Medical Labs
Qiagen
BGI Genomics
MEDx Translational Medicine
Medical Biological Laboratories (MBL)
Novogene

Market Segmentation (by Type)
Feasibility Studies
Assay Development
Analytical Validation
Clinical Validation
Others

Market Segmentation (by Application)
Infectious Diseases
Neurological Disorders

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Companion Diagnostics (CDx) Development Services Market
Overview of the regional outlook of the Companion Diagnostics (CDx) Development Services Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Companion Diagnostics (CDx) Development Services Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Companion Diagnostics (CDx) Development Services, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of Companion Diagnostics (CDx) Development Services
      1.2 Key Market Segments
            1.2.1 Companion Diagnostics (CDx) Development Services Segment by Type
            1.2.2 Companion Diagnostics (CDx) Development Services Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 Companion Diagnostics (CDx) Development Services Market Overview
      2.1 Global Market Overview
            2.1.1 Global Companion Diagnostics (CDx) Development Services Market Size (M USD) Estimates and Forecasts (2020-2033)
            2.1.2 Global Companion Diagnostics (CDx) Development Services Sales Estimates and Forecasts (2020-2033)
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
  3 Companion Diagnostics (CDx) Development Services Market Competitive Landscape
      3.1 Company Assessment Quadrant
      3.2 Global Companion Diagnostics (CDx) Development Services Product Life Cycle
      3.3 Global Companion Diagnostics (CDx) Development Services Sales by Manufacturers (2020-2025)
      3.4 Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Manufacturers (2020-2025)
      3.5 Companion Diagnostics (CDx) Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.6 Global Companion Diagnostics (CDx) Development Services Average Price by Manufacturers (2020-2025)
      3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
      3.8 Companion Diagnostics (CDx) Development Services Market Competitive Situation and Trends
            3.8.1 Companion Diagnostics (CDx) Development Services Market Concentration Rate
            3.8.2 Global 5 and 10 Largest Companion Diagnostics (CDx) Development Services Players Market Share by Revenue
            3.8.3 Mergers & Acquisitions, Expansion
  4 Companion Diagnostics (CDx) Development Services Industry Chain Analysis
      4.1 Companion Diagnostics (CDx) Development Services Industry Chain Analysis
      4.2 Market Overview of Key Raw Materials
      4.3 Midstream Market Analysis
      4.4 Downstream Customer Analysis
  5 The Development and Dynamics of Companion Diagnostics (CDx) Development Services Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Industry News
            5.4.1 New Product Developments
            5.4.2 Mergers & Acquisitions
            5.4.3 Expansions
            5.4.4 Collaboration/Supply Contracts
      5.5 PEST Analysis
            5.5.1 Industry Policies Analysis
            5.5.2 Economic Environment Analysis
            5.5.3 Social Environment Analysis
            5.5.4 Technological Environment Analysis
      5.6 Global Companion Diagnostics (CDx) Development Services Market Porter's Five Forces Analysis
            5.6.1 Global Trade Frictions
            5.6.2 U.S. Tariff Policy – April 2025
            5.6.3 Global Trade Frictions and Their Impacts to Companion Diagnostics (CDx) Development Services Market
      5.7 ESG Ratings of Leading Companies
  6 Companion Diagnostics (CDx) Development Services Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global Companion Diagnostics (CDx) Development Services Sales Market Share by Type (2020-2025)
      6.3 Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2020-2025)
      6.4 Global Companion Diagnostics (CDx) Development Services Price by Type (2020-2025)
  7 Companion Diagnostics (CDx) Development Services Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global Companion Diagnostics (CDx) Development Services Market Sales by Application (2020-2025)
      7.3 Global Companion Diagnostics (CDx) Development Services Market Size (M USD) by Application (2020-2025)
      7.4 Global Companion Diagnostics (CDx) Development Services Sales Growth Rate by Application (2020-2025)
  8 Companion Diagnostics (CDx) Development Services Market Sales by Region
      8.1 Global Companion Diagnostics (CDx) Development Services Sales by Region
            8.1.1 Global Companion Diagnostics (CDx) Development Services Sales by Region
            8.1.2 Global Companion Diagnostics (CDx) Development Services Sales Market Share by Region
      8.2 Global Companion Diagnostics (CDx) Development Services Market Size by Region
            8.2.1 Global Companion Diagnostics (CDx) Development Services Market Size by Region
            8.2.2 Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Region
      8.3 North America
            8.3.1 North America Companion Diagnostics (CDx) Development Services Sales by Country
            8.3.2 North America Companion Diagnostics (CDx) Development Services Market Size by Country
            8.3.3 U.S. Market Overview
            8.3.4 Canada Market Overview
            8.3.5 Mexico Market Overview
      8.4 Europe
            8.4.1 Europe Companion Diagnostics (CDx) Development Services Sales by Country
            8.4.2 Europe Companion Diagnostics (CDx) Development Services Market Size by Country
            8.4.3 Germany Market Overview
            8.4.4 France Market Overview
            8.4.5 U.K. Market Overview
            8.4.6 Italy Market Overview
            8.4.7 Spain Market Overview
      8.5 Asia Pacific
            8.5.1 Asia Pacific Companion Diagnostics (CDx) Development Services Sales by Region
            8.5.2 Asia Pacific Companion Diagnostics (CDx) Development Services Market Size by Region
            8.5.3 China Market Overview
            8.5.4 Japan Market Overview
            8.5.5 South Korea Market Overview
            8.5.6 India Market Overview
            8.5.7 Southeast Asia Market Overview
      8.6 South America
            8.6.1 South America Companion Diagnostics (CDx) Development Services Sales by Country
            8.6.2 South America Companion Diagnostics (CDx) Development Services Market Size by Country
            8.6.3 Brazil Market Overview
            8.6.4 Argentina Market Overview
            8.6.5 Columbia Market Overview
      8.7 Middle East and Africa
            8.7.1 Middle East and Africa Companion Diagnostics (CDx) Development Services Sales by Region
            8.7.2 Middle East and Africa Companion Diagnostics (CDx) Development Services Market Size by Region
            8.7.3 Saudi Arabia Market Overview
            8.7.4 UAE Market Overview
            8.7.5 Egypt Market Overview
            8.7.6 Nigeria Market Overview
            8.7.7 South Africa Market Overview
  9 Companion Diagnostics (CDx) Development Services Market Production by Region
      9.1 Global Production of Companion Diagnostics (CDx) Development Services by Region(2020-2025)
      9.2 Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Region (2020-2025)
      9.3 Global Companion Diagnostics (CDx) Development Services Production, Revenue, Price and Gross Margin (2020-2025)
      9.4 North America Companion Diagnostics (CDx) Development Services Production
            9.4.1 North America Companion Diagnostics (CDx) Development Services Production Growth Rate (2020-2025)
            9.4.2 North America Companion Diagnostics (CDx) Development Services Production, Revenue, Price and Gross Margin (2020-2025)
      9.5 Europe Companion Diagnostics (CDx) Development Services Production
            9.5.1 Europe Companion Diagnostics (CDx) Development Services Production Growth Rate (2020-2025)
            9.5.2 Europe Companion Diagnostics (CDx) Development Services Production, Revenue, Price and Gross Margin (2020-2025)
      9.6 Japan Companion Diagnostics (CDx) Development Services Production (2020-2025)
            9.6.1 Japan Companion Diagnostics (CDx) Development Services Production Growth Rate (2020-2025)
            9.6.2 Japan Companion Diagnostics (CDx) Development Services Production, Revenue, Price and Gross Margin (2020-2025)
      9.7 China Companion Diagnostics (CDx) Development Services Production (2020-2025)
            9.7.1 China Companion Diagnostics (CDx) Development Services Production Growth Rate (2020-2025)
            9.7.2 China Companion Diagnostics (CDx) Development Services Production, Revenue, Price and Gross Margin (2020-2025)
  10 Key Companies Profile
      10.1 Geneuity-Clinical Research Services
            10.1.1 Geneuity-Clinical Research Services Basic Information
            10.1.2 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Product Overview
            10.1.3 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Product Market Performance
            10.1.4 Geneuity-Clinical Research Services Business Overview
            10.1.5 Geneuity-Clinical Research Services SWOT Analysis
            10.1.6 Geneuity-Clinical Research Services Recent Developments
      10.2 Interpace Biosciences
            10.2.1 Interpace Biosciences Basic Information
            10.2.2 Interpace Biosciences Companion Diagnostics (CDx) Development Services Product Overview
            10.2.3 Interpace Biosciences Companion Diagnostics (CDx) Development Services Product Market Performance
            10.2.4 Interpace Biosciences Business Overview
            10.2.5 Interpace Biosciences SWOT Analysis
            10.2.6 Interpace Biosciences Recent Developments
      10.3 Labcorp
            10.3.1 Labcorp Basic Information
            10.3.2 Labcorp Companion Diagnostics (CDx) Development Services Product Overview
            10.3.3 Labcorp Companion Diagnostics (CDx) Development Services Product Market Performance
            10.3.4 Labcorp Business Overview
            10.3.5 Labcorp SWOT Analysis
            10.3.6 Labcorp Recent Developments
      10.4 Quest Diagnostics
            10.4.1 Quest Diagnostics Basic Information
            10.4.2 Quest Diagnostics Companion Diagnostics (CDx) Development Services Product Overview
            10.4.3 Quest Diagnostics Companion Diagnostics (CDx) Development Services Product Market Performance
            10.4.4 Quest Diagnostics Business Overview
            10.4.5 Quest Diagnostics Recent Developments
      10.5 Q² Solutions
            10.5.1 Q² Solutions Basic Information
            10.5.2 Q² Solutions Companion Diagnostics (CDx) Development Services Product Overview
            10.5.3 Q² Solutions Companion Diagnostics (CDx) Development Services Product Market Performance
            10.5.4 Q² Solutions Business Overview
            10.5.5 Q² Solutions Recent Developments
      10.6 ResearchDx
            10.6.1 ResearchDx Basic Information
            10.6.2 ResearchDx Companion Diagnostics (CDx) Development Services Product Overview
            10.6.3 ResearchDx Companion Diagnostics (CDx) Development Services Product Market Performance
            10.6.4 ResearchDx Business Overview
            10.6.5 ResearchDx Recent Developments
      10.7 Almac Diagnostic Services
            10.7.1 Almac Diagnostic Services Basic Information
            10.7.2 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Product Overview
            10.7.3 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Product Market Performance
            10.7.4 Almac Diagnostic Services Business Overview
            10.7.5 Almac Diagnostic Services Recent Developments
      10.8 Biocartis
            10.8.1 Biocartis Basic Information
            10.8.2 Biocartis Companion Diagnostics (CDx) Development Services Product Overview
            10.8.3 Biocartis Companion Diagnostics (CDx) Development Services Product Market Performance
            10.8.4 Biocartis Business Overview
            10.8.5 Biocartis Recent Developments
      10.9 Cerba Research
            10.9.1 Cerba Research Basic Information
            10.9.2 Cerba Research Companion Diagnostics (CDx) Development Services Product Overview
            10.9.3 Cerba Research Companion Diagnostics (CDx) Development Services Product Market Performance
            10.9.4 Cerba Research Business Overview
            10.9.5 Cerba Research Recent Developments
      10.10 Eurofins Scientific
            10.10.1 Eurofins Scientific Basic Information
            10.10.2 Eurofins Scientific Companion Diagnostics (CDx) Development Services Product Overview
            10.10.3 Eurofins Scientific Companion Diagnostics (CDx) Development Services Product Market Performance
            10.10.4 Eurofins Scientific Business Overview
            10.10.5 Eurofins Scientific Recent Developments
      10.11 MLM Medical Labs
            10.11.1 MLM Medical Labs Basic Information
            10.11.2 MLM Medical Labs Companion Diagnostics (CDx) Development Services Product Overview
            10.11.3 MLM Medical Labs Companion Diagnostics (CDx) Development Services Product Market Performance
            10.11.4 MLM Medical Labs Business Overview
            10.11.5 MLM Medical Labs Recent Developments
      10.12 Qiagen
            10.12.1 Qiagen Basic Information
            10.12.2 Qiagen Companion Diagnostics (CDx) Development Services Product Overview
            10.12.3 Qiagen Companion Diagnostics (CDx) Development Services Product Market Performance
            10.12.4 Qiagen Business Overview
            10.12.5 Qiagen Recent Developments
      10.13 BGI Genomics
            10.13.1 BGI Genomics Basic Information
            10.13.2 BGI Genomics Companion Diagnostics (CDx) Development Services Product Overview
            10.13.3 BGI Genomics Companion Diagnostics (CDx) Development Services Product Market Performance
            10.13.4 BGI Genomics Business Overview
            10.13.5 BGI Genomics Recent Developments
      10.14 MEDx Translational Medicine
            10.14.1 MEDx Translational Medicine Basic Information
            10.14.2 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Product Overview
            10.14.3 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Product Market Performance
            10.14.4 MEDx Translational Medicine Business Overview
            10.14.5 MEDx Translational Medicine Recent Developments
      10.15 Medical Biological Laboratories (MBL)
            10.15.1 Medical Biological Laboratories (MBL) Basic Information
            10.15.2 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Product Overview
            10.15.3 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Product Market Performance
            10.15.4 Medical Biological Laboratories (MBL) Business Overview
            10.15.5 Medical Biological Laboratories (MBL) Recent Developments
      10.16 Novogene
            10.16.1 Novogene Basic Information
            10.16.2 Novogene Companion Diagnostics (CDx) Development Services Product Overview
            10.16.3 Novogene Companion Diagnostics (CDx) Development Services Product Market Performance
            10.16.4 Novogene Business Overview
            10.16.5 Novogene Recent Developments
  11 Companion Diagnostics (CDx) Development Services Market Forecast by Region
      11.1 Global Companion Diagnostics (CDx) Development Services Market Size Forecast
      11.2 Global Companion Diagnostics (CDx) Development Services Market Forecast by Region
            11.2.1 North America Market Size Forecast by Country
            11.2.2 Europe Companion Diagnostics (CDx) Development Services Market Size Forecast by Country
            11.2.3 Asia Pacific Companion Diagnostics (CDx) Development Services Market Size Forecast by Region
            11.2.4 South America Companion Diagnostics (CDx) Development Services Market Size Forecast by Country
            11.2.5 Middle East and Africa Forecasted Sales of Companion Diagnostics (CDx) Development Services by Country
  12 Forecast Market by Type and by Application (2026-2033)
      12.1 Global Companion Diagnostics (CDx) Development Services Market Forecast by Type (2026-2033)
            12.1.1 Global Forecasted Sales of Companion Diagnostics (CDx) Development Services by Type (2026-2033)
            12.1.2 Global Companion Diagnostics (CDx) Development Services Market Size Forecast by Type (2026-2033)
            12.1.3 Global Forecasted Price of Companion Diagnostics (CDx) Development Services by Type (2026-2033)
      12.2 Global Companion Diagnostics (CDx) Development Services Market Forecast by Application (2026-2033)
            12.2.1 Global Companion Diagnostics (CDx) Development Services Sales (K Units) Forecast by Application
            12.2.2 Global Companion Diagnostics (CDx) Development Services Market Size (M USD) Forecast by Application (2026-2033)
  13 Conclusion and Key Findings
Geneuity-Clinical Research Services
Interpace Biosciences
Labcorp
Quest Diagnostics
Q² Solutions
ResearchDx
Almac Diagnostic Services
Biocartis
Cerba Research
Eurofins Scientific
MLM Medical Labs
Qiagen
BGI Genomics
MEDx Translational Medicine
Medical Biological Laboratories (MBL)
Novogene
Please select License
Single User Price:$ 3200
Site License Price:$ 6400
Enterprise Price:$ 6400